Library — CHDR

Search

Filter

A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation.

Prins S, Zhuparris A, Hart EP, Doll RJ, Groeneveld GJ

Alzheimer's research & therapy, 2021 Jul; 13(1):132

View publication
Accelerating vaccine trial conduct in a pandemic with a hot spot-based inclusion strategy using trial and epidemic simulation.

van der Plas JL, van Esdonk MJ, Kamerling IMC, Cohen AF

Clinical and translational science, 2021 Jul

View publication
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study.

Woei-A-Jin FJSH, Weijl NI, Burgmans MC, Fariña Sarasqueta A, van Wezel JT, Wasser MNJM, Coenraad MJ, Burggraaf J, Osanto S

The oncologist, 2021 Jul

View publication
Commentary on "Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies" by Sievers et al.

Rissmann R, Zuiker R

British journal of clinical pharmacology, 2021 Jul; 87(7):2633-2634

View publication
The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature.

Kruizinga MD, Peeters D, van Veen M, van Houten M, Wieringa J, Noordzij JG, Bekhof J, Tramper-Stranders G, Vet NJ, Driessen GJA

European journal of pediatrics, 2021 Jul; 180(7):2271-2279

View publication
The impact of the global COVID-19 pandemic on the conduct of clinical trials: Return to normalcy by considering the practical impact of a structured ethical analysis.

Vissers MFJM, Cohen AF, Van Gerven JMA, Groeneveld GJ

British journal of clinical pharmacology, 2021 Jun; 87(3):837-844

View publication
Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.

Berger B, Brooks S, Zuiker R, Richard M, Muehlan C, Dingemanse J

CNS drugs, 2021 Jun; 34(12):1253-1266

View publication
First Clinical Study with AP30663 - a K 2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation.

Gal P, Klaassen ES, Bergmann KR, Saghari M, Burggraaf J, Kemme MJB, Sylvest C, Sørensen U, Bentzen BH, Grunnet M, Diness JG, Edvardsson N

Clinical and translational science, 2021 Jun; 13(6):1336-1344

View publication
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma.

de Valk KS, Deken MM, Handgraaf HJM, Bhairosingh SS, Bijlstra OD, van Esdonk MJ, Terwisscha van Scheltinga AGT, Valentijn ARPM, March TL, Vuijk J, Peeters KCMJ, Holman FA, Hilling DE, Mieog JSD, Frangioni JV, Burggraaf J, Vahrmeijer AL

Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 Jun; 26(15):3990-3998

View publication

«
1
2
3
4
5
6
7
8
...
85
86
»